ArticleCancer cell international2022

Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance.

Ayumi Kanemaru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.